Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, l...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d465 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2d9e543844bd4114a11a1986f1c6d465 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2d9e543844bd4114a11a1986f1c6d4652021-11-25T17:10:27ZRecent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies10.3390/cells101130172073-4409https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d4652021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3017https://doaj.org/toc/2073-4409Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.Anna-Lena MuellerZahra PayandehNiloufar MohammadkhaniShaden M. H. MubarakAlireza ZakeriArmina Alagheband BahramiAranka BrockmuellerMehdi ShakibaeiMDPI AGarticlerheumatoid arthritisinflammationauto-antibodiesautophagyepigeneticcitrullinationBiology (General)QH301-705.5ENCells, Vol 10, Iss 3017, p 3017 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
rheumatoid arthritis inflammation auto-antibodies autophagy epigenetic citrullination Biology (General) QH301-705.5 |
spellingShingle |
rheumatoid arthritis inflammation auto-antibodies autophagy epigenetic citrullination Biology (General) QH301-705.5 Anna-Lena Mueller Zahra Payandeh Niloufar Mohammadkhani Shaden M. H. Mubarak Alireza Zakeri Armina Alagheband Bahrami Aranka Brockmueller Mehdi Shakibaei Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
description |
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation. |
format |
article |
author |
Anna-Lena Mueller Zahra Payandeh Niloufar Mohammadkhani Shaden M. H. Mubarak Alireza Zakeri Armina Alagheband Bahrami Aranka Brockmueller Mehdi Shakibaei |
author_facet |
Anna-Lena Mueller Zahra Payandeh Niloufar Mohammadkhani Shaden M. H. Mubarak Alireza Zakeri Armina Alagheband Bahrami Aranka Brockmueller Mehdi Shakibaei |
author_sort |
Anna-Lena Mueller |
title |
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
title_short |
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
title_full |
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
title_fullStr |
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
title_full_unstemmed |
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies |
title_sort |
recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d465 |
work_keys_str_mv |
AT annalenamueller recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT zahrapayandeh recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT niloufarmohammadkhani recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT shadenmhmubarak recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT alirezazakeri recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT arminaalaghebandbahrami recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT arankabrockmueller recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies AT mehdishakibaei recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies |
_version_ |
1718412638298308608 |